XENE 8-K: SEC filing

Xenon Pharmaceuticals

Filed with the SEC on Nov 9, 2026 · accession 0001193125-26-453521

XENE filed a 8-K (current report) with the SEC on Nov 9, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The stock moved +3.3% by the first close after the filing.

Summary of the filing

Xenon Pharmaceuticals announced its financial results for the three and nine months ended September 30, 2026, via a press release furnished under Item 2.02 of Form 8-K.

For details, click here →How to read a 8-K →

Key details

RegistrantXenon Pharmaceuticals Inc.

Chief financial officerThomas P. Kelly

How XENE stock reacted

Close before

$39.17

Nov 6, 2026

First close after

+3.27%

$40.45

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for XENE, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for XENE?

Click here

Frequently asked questions

What did XENE file with the SEC on Nov 9, 2026?

XENE filed a 8-K (SEC filing). Xenon Pharmaceuticals announced its financial results for the three and nine months ended September 30, 2026, via a press release furnished under Item 2.02 of Form 8-K.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did XENE stock react to this filing?

XENE closed at $39.17 before the filing and $40.45 on Nov 9, 2026 (+3.27%).

Other XENE SEC filings

Get alerts when XENE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

XENE overview XENE analysis XENE news Latest SEC filings